|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Hyperoxia increases free radical production, leading to DNA damage. Recent studies indicate that oxygen augments the expression of p53 and p21WAF1/CIP1, and increases apoptotic labeling of airway epithelial cells. Similar changes in regulatory gene products have not been reported in other pulmonary cells, nor have these changes been investigated in conjunction with alterations in cell-cycle distribution. The present study was conducted to determine whether oxygen alters the expression of p53 and p21WAF1/CIP1 in human bronchial smooth-muscle cells (BSMC). BSMC placed in room air (RA), 40% O2, or 95% O2 were examined for 3 d to determine cell number, thymidine incorporation, cell-cycle distribution, and lactate dehydrogenase release. Apoptosis was assessed through the terminal deoxynucleotidyl transferase-deoxyuridine triphosphate end-nick labeling (TUNEL) technique, and p53 and p21WAF1/CIP1 protein levels were determined through enzyme-linked immunosorbent assay. Exposure of BSMC to 95% O2 decreased proliferation and DNA synthesis within 24 h, and was accompanied by an increase in S-phase cells (72 h; RA: 12.9 ± 4.6%, versus 95% O2: 34.6 ± 7.0%; P < 0.01). By comparison, exposure to 40% O2 resulted in decreased proliferation at 48 h without significant alterations in cell-cycle distribution. Both p53 and p21WAF1/CIP1 levels were increased by 95% O2, with maximal differences noted at 24 and 48 h, respectively. All atmospheres showed < 8% cell death and few TUNEL-positive cells. Our results indicate that oxygen-mediated alterations in BSMC proliferation are time- and concentration-dependent. Furthermore, high oxygen levels induce S-phase arrest and increased expression of p53 and p21WAF1/CIP1. Activation of these genes may prevent replication without inducing apoptosis to allow for the repair of oxidative damage.
| |
Introduction |
|---|
|
|
|---|
Although it has been well established that exposure to supraphysiologic concentrations of oxygen inhibits pulmonary cell proliferation, the mechanism leading to this effect
remains in question (1). Recent reports suggest that oxidizing agents and oxygen free radicals can indirectly activate
cell-cycle regulatory genes by inducing DNA damage, resulting in profound growth inhibition without cell death (4,
5). One of these regulatory genes encodes p21WAF1/CIP1 protein, a cyclin-dependent kinase (cdk) inhibitor. p21WAF1/CIP1
is capable of binding to G1 cyclin-cdk complexes to prevent the phosphorylation of retinoblastoma gene protein
and the activation of the E2F pathway necessary for entrance of cells into the S phase of the cell cycle (6). Regulation of the G1/S transition by p21WAF1/CIP1 has been linked
to both p53-dependent and -independent mechanisms (5).
Arrest of the cell cycle at the G1/S checkpoint is believed to avert replication of damaged DNA templates, which
would lead to genomic instability (6, 7). p21WAF1/CIP1 has
also been shown to regulate DNA replication within the
S phase in vitro, by binding to proliferating-cell nuclear antigen (PCNA)/cdk complexes and by dissociating cyclin
A/cdk2/p107/E2F transitional complexes (8). These interactions block strand elongation by DNA polymerase
,
and have been shown to occur with and without DNA
damage (6, 8, 9).
Recently, it was reported that exposure of mice to 95% O2 for 72 h induces upregulation of p53 and p21WAF1/CIP1 messenger RNA (mRNA) and protein in airway epithelium coincidentally with a decrease in cellular bromodeoxyuridine uptake (13, 14). This suggests that oxygen-mediated alterations in gene expression can regulate epithelial cell proliferation, thereby influencing lung growth and development (13, 14). However, whether the changes in gene expression documented in epithelial cells extend to other pulmonary cell types injured by exposure to oxygen, and whether the alterations in regulatory gene expression are associated with specific cell-cycle derrangements, is unknown. Therefore, we conducted the present study to determine the impact of oxygen on actively proliferating human bronchial smooth-muscle cells (BSMC), and to assess whether abnormalities in cell-cycle phase distribution would be associated with increased expression of cell-cycle-regulatory gene products. We hypothesized that oxygen-induced reductions in DNA synthesis in BSMC would be associated with alterations in cell-cycle distribution and with increased expression of p53 and p21WAF1/CIP1 proteins.
| |
Materials and Methods |
|---|
|
|
|---|
Cells and Culture Conditions
Normal human adult BSMC were obtained from Clonetics
(Division of BioWhittaker, Inc., Walkersville, MD) and
grown in 6- or 24-well plates and in smooth-muscle growth
medium (Clonetics modified Molecular Cellular Developmental Biology [MCDB] medium 131 + 0.5 µg/liter epidermal growth factor + 2 µg/liter fibroblast growth factor-
1 + 5 mg/liter insulin + 50 mg/liter gentamicin + 50 mg/liter amphotericin + 5% fetal bovine serum [FBS]). These cells
stain positively for
-smooth-muscle actin (Sigma, St. Louis,
MO) and display the typical "hill and valley" morphology
of smooth-muscle cells when confluent. Passage-5-7 cells
seeded at 3,000 cells/cm2 were allowed to attach overnight
in room air (RA) + 5% CO2 at 37°C. Human neonatal lung
fibroblasts (NLF) were obtained from a bronchial biopsy
specimen from an infant with bronchopulmonary dysplasia. NLF were grown as previously described, and stained positively for vimentin but not for smooth-muscle myosin
(15). Passage-9-12 NLF grown in M3 medium + 10% FBS
were utilized to confirm flow-cytometric findings, and were
treated and cultured analogously to BSMC cultures. The
effect of oxygen exposure on both BSMC and NLF growth
was determined by placing plates into humidified modular
incubators (Billups-Rothenberg, Del Mar, CA) flushed
with RA, 40% O2, or 95% O2 + 5% CO2 + balanced N2 at
37°C for 72 h following cell attachment.
Morphology
The effect of oxygen on gross cell morphology was determined with cells grown in four-chamber Labtech slides (Fisher Scientific, Pittsburgh, PA). Cells were fixed in 1% paraformaldehyde and 70% ethanol, and were then stained with hematoxylin and eosin (H&E; Sigma). Morphology was assessed at a magnification of ×200, using an Optiphot microscope (Nikon, Tokyo, Japan).
Proliferation Studies
Monolayers were harvested by incubation with 0.5% trypsin + 1 mM ethylenediamine tetraacetic acid (EDTA) (Sigma) for 2-3 min. Cell number was then determined by counting cells from duplicate chambers with a hemacytometer. DNA synthesis was assessed through thymidine incorporation by cells pulsed for 16 h with 10 µCi/ml [3H]thymidine (Amersham, Arlington Heights, IL). On the morning after the pulse treatment, monolayers were rinsed in phosphate-buffered saline (PBS), and DNA was precipitated by incubating with 10% trichloroacetic acid for 24 h. Samples were then denatured in NaOH and analyzed on a scintillation counter.
Mitochondrial Function
Because alterations in mitochondrial physiology have been linked to both growth arrest and apoptosis, the conversion of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) to formazen by respiratory enzymes was studied as an index of cellular mitochondrial function (CellTiter 96; Promega, Madison, WI). Conversion was measured by adding 40 µl of MTS per well to samples in 96-well plates, and incubating at 37°C for 4 h. The optical density at 490 nm (OD490) was then determined on a Dynatech MR5000 plate reader (Dynatech, Chantilly, VA).
Flow Cytometry
BSMC and NLF monolayers were trypsinized and stained in the unfixed state with the CycleTest Plus DNA kit (Becton-Dickinson, San Jose, CA), using a proprietary combination of trypsin, ribonuclease (RNase) A, and propidum iodide (PI). Suspensions were run on an EPICS Profile II flow cytometer (Phoenix Flow Systems, Hialeah, FL), and the resulting DNA histograms were modeled with Multicycle.AV software (Phoenix).
For the detection of apoptosis, free-floating and attached cells from duplicate T25 flasks were trypsinized and counted. Cells were fixed in 1% paraformaldehyde for 30 min, washed in PBS, and permeabilized with ice-cold 70% ethanol. After rinsing, 3' ends of DNA cleavage sites were labeled with the terminal deoxynucleotidyl transferase-dUTP nick-end labeling (TUNEL) technique, using a commercially available kit (APO-Direct, Phoenix) (16). Cells were incubated for 60 min at 37°C in terminal deoxyuridine transferase/fluorescein-dUTP, rinsed, and incubated with PI/RNase A for 30 min. Flow cytometry was conducted with gating parameters established on campothecin-treated HL-60 cells supplied by Phoenix.
Lactate Dehydrogenase Release
Cell death was determined through released lactate dehydrogenase (LDH) (1). Media-derived and cellular LDH were measured colorimetrically, using pyruvate as a substrate and NAD/oxidase as a detector (Sigma). High- and low-concentration LDH standards (Sigma) were run during each assay to validate the LDH calibration curve. Cellular LDH content was determined on scraped cells that had been sonicated for 2 min. The percent LDH release was then determined by dividing the content of LDH in the medium by the total LDH per well.
Enzyme-Linked Immunosorbent Assay for p53 and p21WAF1/CIP1
Free-floating and attached cells were counted on a hemacytometer prior to assaying for p53 and p21WAF1/CIP1 with enzyme-linked immunosorbent assays (ELISA) (Oncogene, Cambridge, MA). Briefly, cells were centrifuged and resuspended in 200 µl of 10 mM Tris + 5 mM EDTA + 0.2 mM phenylmethylsulfonyl fluoride + 1 µg/ml pepstatin + 0.5 µg/ml leupeptin (pH, 7.4). Antigen was extracted by adding 40 µl of extraction reagent (Oncogene) to the cell suspension and incubating on ice for 30 min. Determination of peptide concentrations was done by adding 100 µl of cell lysate to 96-well plates preabsorbed with either mouse monoclonal anti-p53 or rabbit polyclonal anti-p21WAF1/CIP1 antibody. Plates were incubated for 2 h, washed, and incubated for 1 h with 100 µl biotinylated mouse monoclonal anti-p53 or p21WAF1/CIP1 antibody. The presence of secondary antibody was detected colorimetrically through the use of streptavidin-horseradish peroxidase, with tetramethylbenzidine as the chromogen. Color change was read at 450 /540 nm on a Dynatech plate reader (Chantilly, VA), and corresponding peptide concentrations were extrapolated from a standard curve produced from known concentrations of p53 and p21WAF1/CIP1 peptide supplied by the ELISA manufacturer. The sensitivities of the assays as reported by the manufacturer are 0.012 ng/ml for p53 and 0.1 U/ml for p21WAF1/CIP1 (1 U = [p21WAF1/CIP1 from 2.7 × 105 MCF7 cells]). Values derived from the standard curves were normalized to 104 cells.
Statistics
All parameters, except apoptosis, were analyzed through
repeated measures analysis of variance (ANOVA), followed by pairwise comparisons made with Newman-Keuls
test, using GB-STAT software (Dynamic Microsystems,
Silver Springs, MD). Apoptosis data were rendered descriptively. Reported values represent mean ± SD, with the level of significance set at P
0.05.
| |
Results |
|---|
|
|
|---|
Effect of Oxygen on Cell Morphology
BSMC exposed to 95% O2 displayed progressive long-axis shortening over time, with a generalized loss of the spindle-shaped phenotype. Cells exposed to 40% O2 appeared similar in phenotype to control cells, but were fewer in number at 48 and 72 h (Figure 1).
|
Effects of Oxygen on Cell Proliferation and Mitochondrial Function
Exposure of BSMC to 95% O2 led to a rapid decrease in cell proliferation, with no significant change in cell number occurring beyond 24 h (Figure 2a). Although cells exposed to 40% O2 also showed decreased proliferation as compared with RA-treated cells, the net effect was not apparent until 72 h. As would be expected from the cell-number data, DNA synthesis was negatively affected by increasing oxygen concentration and exposure (P < 0.0001) (Figure 2b). At 72 h, DNA synthesis in 40% O2- and 95% O2-treated BSMC was reduced to just 22% and 7% of RA cells, respectively.
|
In addition to its effects on cell division, oxygen altered mitochondrial function in a concentration- and time-dependent manner (P < 0.0001) (Figure 3). The results reveal that 95% O2 reduced the conversion of MTS to formazen within 24 h, whereas 40% O2 appeared to have little effect until 48 h. Furthermore, MTS conversion in 95% O2-treated cells was below the baseline value at each of the subsequent 24-h periods (time-0 versus 24, 48, and 72 h; P < 0.05).
|
Effect of Oxygen on Cell-Cycle Distribution and Cell Death
In BSMC, all phases of the cell cycle were altered by oxygen exposure, although the distribution pattern of 95% O2-treated cells changed little over the 72-h period (Figures 4 and 5). As compared with exposure to RA, exposure to 95% O2 caused a marked accumulation of cells in the S-phase and a reduction of cells in the G2/M phase at 24 and 48 h. By 72 h, not only were a greater percentage of 95% O2-treated cells in S phase (RA: 12.9 ± 4.6%, versus 95% O2: 34.6 ± 7.0%, P < 0.01), but also a smaller fraction of 95% O2-treated cells than cells exposed to RA were in the G0/G1 phase (RA: 76.4 ± 8.7%, versus 95% O2: 59.3 ± 6.0%; P < 0.01). By contrast, exposure to 40% O2 changed the cell-cycle distribution little until 72 h, at which time there appeared to be a shift in distribution into the G2/M phase. To assess whether the alterations in cell-cycle distribution were unique to BSMC, we exposed NLF to room air and 95% O2 under identical conditions. Once again, we found that exposure to 95% O2 produced an accumulation of cells in the S phase on each of the three days of exposure, which was more than 2-fold greater than RA-treated cells at 72 h (RA: 12.6 ± 1.8%, versus 95% O2: 28.8 ± 1.9%; P < 0.01). As with BSMC, S-phase changes were accompanied by reductions in the fraction of cells in the G0/G1 and G2/M phases.
|
|
We found a small but significant increase in percent LDH release from all cell groups over time (range: 2.1% at 24 h; 4.4% at 72 h; P < 0.05). Nevertheless, there were no differences in the percent LDH released among cells exposed to the three oxygen concentrations at any time point. Using TUNEL labeling, we were able to detect apoptosis in 23.8% of the camptothecin-treated HL-60 cells. In BSMC, however, the percentage of apoptotic cells was extremely low at all times and under all conditions, being approximately 0.3% at time-0 and less than 0.1% thereafter.
Effect of Oxygen on p53 and p21WAF1/CIP1
p53 and p21WAF1/CIP1 proteins were detected in all cell groups at all time points, and each value exceeded the known lower limit of detection of the ELISAs for these proteins by at least a factor of five. Both p53 and p21WAF1/CIP1 were affected by oxygen and by the duration of exposure (P < 0.05). As shown in Figure 6a, p53 levels tended to decrease over time. Nevertheless, p53 protein per cell was greater in 95% O2-exposed than in RA-exposed cells throughout the study period, with significant differences being observed at 24 and 72 h. The levels of p21WAF1/CIP1, on the other hand, remained constant during the 72-h study in both RA- and 40% O2-exposed BSMC (Figure 6b). Cells exposed to 95% O2, however, showed a generalized increase in p21WAF1/CIP1 protein/cell over time, which was maximal at 48 h (RA: 0.57 ± 0.20, versus 95% O2: 1.29 ± 0.26 U/ml/104 cells; P < 0.01).
|
| |
Discussion |
|---|
|
|
|---|
Numerous studies have demonstrated the ability of oxygen to slow the proliferation of cells grown in culture. Alveolar type II cells, fibroblasts, and tracheal smooth-muscle cells all exhibit decreased growth within 24 h of exposure to O2 fractions exceeding 50% O2 (1, 16). This high-oxygen environment increases the generation of reactive oxygen species (ROS) and fosters the release of H2O2 from mitochondria, either of which effect may lead to DNA strand breaks, protein oxidation, and lipid peroxidation (17, 18). Although an abundance of literature has focused on the nucleus as a central target of oxidative damage, it is clearly not the only organelle injured by oxygen. Yakes and Van Houten recently demonstrated that ROS-induced injury of mitochondrial DNA is more extensive, and repair less rapid, than for nuclear DNA (19). In addition, hyperoxia has been shown to diminish mitochondrial energy production by inactivating key respiratory enzymes such as aconitase and reduced nicotinamide adenine dinucleotide-oxidase (20, 21). These alterations may then promote a stress response that culminates in either growth arrest or apoptosis. Because of the intimate involvement of mitochondria in proliferative and apoptotic signaling, we examined the impact of hyperoxia on mitochondrial function, using the bioreduction of MTS. We found that exposure of BSMC to 95% O2 rapidly and profoundly reduced DNA synthesis without inducing apoptosis, a finding that has previously been made in hyperoxia-exposed A549 cells (22). At the same time, we also found a marked depression in mitochondrial respiration in 95% O2. By exposing cells to a lower oxidative load, however, we were able to show that reductions in DNA synthesis precede reductions in MTS absorbance, indicating that oxygen-mediated inhibition of mitochondrial energy production is unlikely to instigate the loss of DNA synthetic capacity.
The cessation of proliferation observed during oxidative stress is believed to represent a basic protective mechanism that prevents the replication of damaged template
DNA. Classically, cell-cycle arrest occurs at one of two
well-defined checkpoints: the G1/S transition or the G2/M
transition (23). Nevertheless, we found that both BSMC
and NLF grown in 95% O2 accumulated to the greatest degree within the S phase, a response that appeared early
and was sustained throughout the study period. Although unexpected, this finding is consistent with the existence of
a damage-sensitive checkpoint within the S phase. In yeast,
this regulatory site involves a complex signal-transduction
pathway initiated by the recognition of damage by DNA
polymerase
and propagated through the activation of the
lipid and protein kinase genes MEC1 and RAD53 (24, 25).
An analogous pathway in mammalian cells involves the
ataxia-telangiectasia-mutated (ATM) gene (26). The ATM
gene has been found to have oxidative stress- and DNA damage-sensing properties, and to regulate cell-cycle progression (26, 27). The gene not only regulates the G1/S and
G2/M phase transitions by activating p53 and p21WAF1/CIP1,
but also controls S-phase traversal by altering the DNA-binding capacity of replication protein A (26, 27). In essence, the ATM gene serves a managerial function for the
cell, coordinating injury detection, cell-cycle progression,
and repair.
Throughout the cell cycle, progression is controlled by a series of cyclins and cdks that are in turn regulated by cdk inhibitors such as p21WAF1/CIP1, p27kip1, p16, and others (6, 28, 29). In normal cells, p21WAF1/CIP1 exists in quaternary complexes with cyclins, cdks, and PCNA (6, 30). Overexpression of p21WAF1/CIP1 alters the stoichiometric relationship within the complex, leading to growth arrest either through the inactivation of E2F transcriptional factors in late G1 or through the dissociation of cyclin A from the p107/cdk2/E2F transitional complex in the S phase (8, 10, 12). Although the observation that hyperoxia-treated BSMC accumulate in the S phase and show increased p21WAF1/CIP1 expression implies participation of p21WAF1/CIP1 in S-phase regulation, the association may not be causal. A recent study of diploid fibroblasts found that bleomycin-induced DNA damage increased p53 and p21WAF1/CIP1 protein expression coincidentally with G1/S- and S-phase arrest. Transfection of these cells with a dominant-negative mutant of p53 abolished the p21WAF1/CIP1 response and the G1/ S blockade, but did not augment DNA synthesis, suggesting that damage sufficient to impair DNA synthesis occurred independently of the p53 surveillance mechanisms regulating p21WAF1/CIP1 expression (31). Furthermore, the induction of DNA strand breaks in colon carcinoma cells, and the subsequent S-phase arrest of these cells, has been shown to precede the upregulation of p53 and p21WAF1/CIP1 proteins, indicating that the arrest is secondary neither to p53-mediated mechanisms nor to p21WAF1/CIP1-induced inactivation of DNA-replicating machinery (32). Additionally, it is conceivable that p21WAF1/CIP1 serves to protect cells from p53-mediated apoptosis, a notion supported by the report that ectopic expression of p21WAF1/CIP1 protects p21WAF1/CIP1-deficient mouse embryonal fibroblasts from p53-mediated apoptotic pathways (33). Thus, during extreme oxidative stress, the upregulation of p21WAF1/CIP1 may initiate growth arrest not only to allow time for cellular repair of damaged DNA, but also to avert premature cell death.
Although our observations contribute to the understanding of oxygen toxicity and cell-cycle regulation, their direct application to oxygen-related disease is less clear. The typical pathophysiologic response of airway smooth-muscle cells to hyperoxia in vivo is proliferative, driven by the stimulation of mitogens released from inflammatory cells, epithelial cells, and fibroblasts (34). Because the levels of oxidative stress utilized in the present study exceeded those experienced by cells in the airway wall, one could argue that oxygen-induced growth arrest without apoptosis is purely an in vitro phenomenon. This conclusion is strengthened by the knowledge that hyperoxia induces apoptosis in the airway epithelium of mice but necrosis in cultured A549 cells, a dichotomy that most likely reflects the influence of cell-cell interactions and inflammatory mediators in vivo (22, 35, 36). Nevertheless, studies in the rat indicate that the replicative response of airway smooth-muscle cells to 95% O2 is dynamic and follows a pattern similar to that of the airway epithelium (37, 38). Although data are lacking on the acute smooth-muscle response to hyperoxia, it would seem reasonable to postulate that airway smooth-muscle cells, like their epithelial counterparts, experience a reduction in proliferation during this period (14). Subsequent mitogenic stimulation might then induce a relative overexpression of cyclins A and D1, prompting the return of cell-cycle progression, a process described in fibroblasts constitutively expressing p21WAF1/CIP1 and in alveolar epithelial cells recovering from hyperoxic injury (10, 39).
In conclusion, we have shown that oxygen produces graded reductions in DNA synthesis and mitochondrial function in BSMC, and that extremely high concentrations of oxygen induce an accumulation of cells in the S phase of the cell cycle. These changes occur in conjunction with increased expression of p53 and p21WAF1/CIP1 proteins, but without significant cell loss, suggesting that upregulation of cell-cycle regulatory genes occurs to promote cellular repair rather than apoptosis.
| |
Footnotes |
|---|
Address correspondence to: Jeffrey S. Shenberger, MAJ USAF MC, Department of Pediatrics/MMNP, Wilford Hall USAF Medical Center, 2200 Bergquist Drive, Suite 1, Lackland AFB, TX 78236-5300. E-mail: jedielni{at}hotmail.com
(Received in original form October 29, 1998 and in revised form February 19, 1999).
The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or other Departments of the U.S. Government.Acknowledgments: The authors would like to thank Dr. Stephen X. Skapek for reviewing the manuscript and for numerous conversations on cell-cycle regulation.
| |
References |
|---|
|
|
|---|
1. Absher, M., W. Makrides, P. Shapiro, and J. N. Evans. 1994. Hyperoxia inhibits proliferation of cultured rat tracheal smooth muscle cells. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11):L101-L105.
2. Housset, B., I. Hurbain, J. Masliah, A. Laghsal, M. T. Chaumette-Demaugre, H. Karam, and J. P. Derenne. 1991. Toxic effects of oxygen on cultured alveolar epithelial cells, lung fibroblasts and alveolar macrophages. Eur. Respir. J. 4: 1066-1075 [Abstract].
3. Martin, W. J., and D. L. Kachel. 1989. Oxygen-mediated impairment of human pulmonary endothelial cell growth: evidence for a specific threshold of toxicity. J. Lab. Clin. Med. 13: 413-421 .
4. Bladier, C., E. J. Wolveang, P. Hutchinson, J. B. de Haan, and I. Kola. 1997. Response of a primary human fibroblast cell line to H2O2: senescence-like growth arrest or apoptosis? Cell Growth Diff. 8: 589-598 [Abstract].
5.
Russo, T.,
N. Zambrano,
F. Esposito,
R. Ammendola,
F. Cimino,
M. Fiscella,
J. Jackman,
P. M. O'Connor,
C. W. Anderson, and
E. Appella.
1995.
A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress.
J. Biol. Chem.
270:
29386-29391
6. Garatel, A. L., M. S. Serfas, and A. L. Tyner. 1996. p21WAF1/CIP1- negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213: 138-149 [Abstract].
7. Jacks, T., and R. A. Weinberg. 1996. Cell-cycle control and its watchman. Nature 381: 643-644 [Medline].
8. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21WAF1/CIP1 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578 [Medline].
9.
Flores-Rozas, H.,
Z. Kelman,
F. B. Dean,
Z. Q. Pan,
J. W. Harper,
S. J. Elledge,
M. O'Donnell, and
J. Hurwitz.
1994.
Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits replication
catalyzed by DNA polymerase delta holoenzyme.
Proc. Natl. Acad. Sci.
USA
91:
8655-8659
10. Orgryzko, V. V., P. Wong, and B. H. Howard. 1997. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol. Cell Biol. 17: 4877-4882 [Abstract].
11. Li, R., S. Waga, G. Hanon, D. Beach, and B. Stillman. 1994. Differential effects by the p21WAF1/CIP1 CDK inhibitor on PCNA dependent DNA replication and DNA repair. Nature 371: 534-537 [Medline].
12. Afshari, C. A., M. A. Nichols, Y. Xiong, and M. Mudryj. 1996. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Diff. 7: 979-988 [Abstract].
13.
O'Reilly, M. A.,
R. J. Stversky,
B. R. Stripp, and
J. N. Finkelstein.
1998.
Exposure to hyperoxia induces p53 expression in mouse lung epithelium.
Am. J. Respir. Cell Mol. Biol.
18:
43-50
14.
McGrath, S. A..
1998.
Induction of p21WAF1/CIP1 during hyperoxia.
Am. J. Respir. Cell Mol. Biol.
18:
179-187
15. Stancombe, B., W. F. Walsh, S. Derdak, P. Dixon, and D. Hensely. 1993. Induction of human neonatal pulmonary fibroblast cytokines by hyperoxia and Ureaplasma urealyticum. Clin. Infect. Dis. 17: S154-S157 .
16. Clement, A., M. Edeas, K. Chadelat, and J. S. Brody. 1992. Inhibition of lung epithelial cell proliferation by hyperoxia. J. Clin. Invest. 90: 1812-1818 .
17. Turrens, J. F., B. A. Freeman, and J. D. Crapo. 1982. Hyperoxia increases H2O2 release by lung mitochondria and microsomes. Arch. Biochem. Biophys. 217: 411-421 [Medline].
18. Gille, J. J., and H. Joejne. 1992. Cell culture models of oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutat. Res. 275: 405-414 [Medline].
19.
Yakes, F. M., and
B. Van Houton.
1997.
Mitochondrial DNA damage is
more extensive and persists longer than nuclear DNA damage in human
cells following oxidative stress.
Proc. Natl. Acad. Sci. USA
94:
514-519
20.
Gardner, P. R.,
D. H. Nguyen, and
C. W. White.
1994.
Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells
and in rat lungs.
Proc. Natl. Acad. Sci. USA
91:
12248-12252
21. Pruijn, F. B., W. G. E. J. Schoonen, and H. Joejne. 1992. Inactivation of mitochondrial metabolism by hyperoxia-induced oxidative stress. Ann. NY Acad. Sci. 663: 453-455 [Medline].
22.
Kazzaz, J. A.,
J. Xu,
T. A. Palaia,
L. Mantell,
A. M. Fein, and
S. Horowitz.
1996.
Cellular oxygen toxicity: oxidant injury without apoptosis.
J. Biol
Chem.
271:
15182-15186
23.
Hartwell, L. H., and
M. B. Kastan.
1994.
Cell cycle control and cancer.
Science
266:
1821-1828
24. Sanchez, Y., B. A. Desany, W. J. Jones, Q. Liu, B. Wang, and S. J. Elledge. 1996. Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science 271: 357-360 [Abstract].
25.
Navas, T. A.,
Z. Zhou, and
S. J. Elledge.
1995.
DNA polymerase
links the
DNA replication machinery to the S phase checkpoint.
Cell
80:
29-39
[Medline].
26. Rotman, G., and Y. Shiloh. 1997. The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defense against oxidative stress. Cancer Surv. 29: 285-304 [Medline].
27. Larner, J. M., H. Lee, and J. L. Hamlin. 1997. S phase damage sensing checkpoints in mammalian cells. Cancer Surv. 29: 25-45 [Medline].
28. Hunter, T.. 1993. Braking the cycle. Cell 75: 839-841 [Medline].
29.
Aprelikova, O.,
Y. Xiong, and
E. T. Liu.
1995.
Both p16 and p21 families of
cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of
cyclin-dependent kinases by the CDK-activating kinase.
J. Biol. Chem.
270:
18195-18197
30. Zhang, H., Y. Xiong, and D. Beach. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell. 4: 897-906 [Abstract].
31. Wyllie, F. S., M. F. Haughton, J. A. Bond, J. M. Rowson, C. J. Jones, and D. Wynford-Thomas. 1996. S phase cell-cycle arrest following DNA damage is independent of the p53/p21WAF1/CIP1 signaling pathway. Oncogene 12: 1077-1082 [Medline].
32.
Matsui, S.,
M. A. Arrendondo,
C. Wrzosek, and
Y. M. Rustum.
1996.
DNA
damage and p53 induction do not cause ZD1694-induced cell cycle arrest
in human colon carcinoma cells.
Cancer Res.
56:
4715-4723
33. Gorospe, M., C. Cirielli, X. Wang, P. Seth, M. C. Capogrossi, and N. J. Holbrook. 1997. p21Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14: 929-935 [Medline].
34. Hershenson, M. B., E. T. Naureckas, and J. Li. 1997. Mitogen-activated signaling in cultured airway smooth muscle cells. Can. J. Physiol. Pharmacol. 75: 898-910 [Medline].
35. Barazzone, C., D. Belin, P. Piguet, J. Vassalli, and A. Sappino. 1996. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J. Clin. Invest. 98: 2666-2673 [Medline].
36. Otterbein, L. E., B. Y. Chin, L. L. Mantell, L. Stansberry, S. Horowitz, and A. M. K. Choi. 1998. Pulmonary apoptosis in aged and oxygen-tolerant rats exposed to hyperoxia. Am J. Physiol. 275 (Lung Cell Mol. Physiol.): L14-L20.
37. Hershenson, M. B., M. D. Kelleher, E. T. Naureckas, M. K. Abe, V. J. Rubinstein, A. Zimmerman, A. M. Bendele, J. A. McNulty, R. A. Panettieri, and J. Solway. 1994. Hyperoxia increases airway cell S-phase traversal in immature rats in vivo. Am. J. Respir. Cell Mol. Biol. 11: 296-303 [Abstract].
38. Shenberger, J. S., R. L. Shew, and D. E. Johnson. 1997. Hyperoxia-induced airway remodeling and pulmonary neuroend [Medline]
This article has been cited by other articles:
![]() |
J. S. Shenberger, J. L. Myers, S. G. Zimmer, R. J. Powell, and A. Barchowsky Hyperoxia alters the expression and phosphorylation of multiple factors regulating translation initiation Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L442 - L449. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhou, J. Li, A. M. Goldsmith, D. C. Newcomb, D. M. Giannola, R. G. Vosk, E. M. Eves, M. R. Rosner, J. Solway, and M. B. Hershenson Human Bronchial Smooth Muscle Cell Lines Show a Hypertrophic Phenotype Typical of Severe Asthma Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Helt, R. J. Staversky, Y.-J. Lee, R. A. Bambara, P. C. Keng, and M. A. O'Reilly The Cdk and PCNA domains on p21Cip1 both function to inhibit G1/S progression during hyperoxia Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L506 - L513. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. May, P. Strobel, T. Preisshofen, S. Seidenspinner, A. Marx, and C.P. Speer Apoptosis and proliferation in lungs of ventilated and oxygen-treated preterm infants Eur. Respir. J., January 1, 2004; 23(1): 113 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. O'Reilly, R. H. Watkins, R. J. Staversky, and W. M. Maniscalco Induced p21Cip1 in premature baboons with CLD: implications for alveolar hypoplasia Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L964 - L971. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nyunoya, L. S. Powers, T. O. Yarovinsky, N. S. Butler, M. M. Monick, and G. W. Hunninghake Hyperoxia Induces Macrophage Cell Cycle Arrest by Adhesion-dependent Induction of p21Cip1 and Activation of the Retinoblastoma Protein J. Biol. Chem., September 19, 2003; 278(38): 36099 - 36106. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. O'Reilly, J. M. Hickman-Davis, I. C. Davis, and S. Matalon Hyperoxia Impairs Antibacterial Function of Macrophages Through Effects on Actin Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 443 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. O'Reilly, R. J. Staversky, J. N. Finkelstein, and P. C. Keng Activation of the G2 cell cycle checkpoint enhances survival of epithelial cells exposed to hyperoxia Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L368 - L375. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Pandya, V. A. Snetkov, C. H. C. Twort, J. P. T. Ward, and S. J. Hirst Oxygen regulates mitogen-stimulated proliferation of fetal human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, December 1, 2002; 283(6): L1220 - L1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. MARWICK, P. KIRKHAM, P. S. GILMOUR, K. DONALDSON, W. MacNEE, and I. RAHMAN Cigarette Smoke-Induced Oxidative Stress and TGF-{beta}1 Increase p21waf1/cip1 Expression in Alveolar Epithelial Cells Ann. N.Y. Acad. Sci., November 1, 2002; 973(1): 278 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Staversky, R. H. Watkins, T. W. Wright, E. Hernady, M. B. LoMonaco, C. T. D'Angio, J. P. Williams, W. M. Maniscalco, and M. A. O'Reilly Normal Remodeling of the Oxygen-Injured Lung Requires the Cyclin-Dependent Kinase Inhibitor p21Cip1/WAF1/Sdi1 Am. J. Pathol., October 1, 2002; 161(4): 1383 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Helt, R. C. Rancourt, R. J. Staversky, and M. A. O'Reilly p53-Dependent Induction of p21Cip1/WAF1/Sdi1 Protects against Oxygen-Induced Toxicity Toxicol. Sci., October 1, 2001; 63(2): 214 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. O'Reilly DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L291 - L305. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. O'Reilly, R. J. Staversky, R. H. Watkins, C. K. Reed, K. L. de Mesy Jensen, J. N. Finkelstein, and P. C. Keng The Cyclin-Dependent Kinase Inhibitor p21 Protects the Lung from Oxidative Stress Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 703 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Rancourt, P. C. Keng, C. E. Helt, and M. A. O'Reilly The role of p21CIP1/WAF1 in growth of epithelial cells exposed to hyperoxia Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L617 - L626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ahmad, C. W. White, L.-Y. Chang, B. K. Schneider, and C. B. Allen Glutamine protects mitochondrial structure and function in oxygen toxicity Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L779 - L791. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Potapova, M. Gorospe, F. Bost, N. M. Dean, W. A. Gaarde, D. Mercola, and N. J. Holbrook c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma Cells J. Biol. Chem., August 4, 2000; 275(32): 24767 - 24775. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |